Back to Journals » OncoTargets and Therapy » Volume 9

Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma

Total article views   HTML views PDF downloads Totals
6,814 Dovepress* 6,309+ 1,330 7,639
PubMed Central* 505 185 690
Totals 6,814 1,515 8,329
*Since 25 July 2016

View citations on PubMed Central and Google Scholar